查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球創傷產品市場-2022-2029
市場調查報告書
商品編碼
1140715

全球創傷產品市場-2022-2029

Global Trauma Products Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

創傷產品的市場規模預計在 2021 年達到 81.49 億美元，到 2029 年達到 132.67 億美元，在預測期間（2022-2029 年）以 6.5% 的複合年增長率增長據說，

創傷是突然發生並需要立即就醫的任何身體傷害，例如骨折、燒傷、扭傷、脫臼和拉傷。市場主要由創傷產品的可用性主導，例如內固定器、外固定器、運動醫學設備、籠子、角刀片、電動工具和弧形棒。

市場動態

全球創傷產品市場正在增長，這得益於多種因素，包括全球範圍內遭受創傷的人數不斷增加、新創傷產品的批准以及新技術的進步。

創傷發病率的上升和各種新技術的進步預計將推動市場增長。

對創傷產品不斷增長的需求推動了市場的發展，並增加了全球遭受創傷的人數。根據世界衛生組織 (WHO) 的數據，全世界每年約有 500 萬人死於創傷性傷害，例如交通事故、溺水、中毒、跌倒和燒傷、襲擊和自殘以及戰爭行為造成的暴力。每年約有 30% 的 65 歲及以上的人跌倒，約 40% 的 75 歲及以上的人跌倒。大約 40-60% 的跌倒導致受傷，10% 是重傷，5% 是骨折。

市場正在見證創傷診斷產品的技術進步，以改善腦損傷的檢測。例如，Medicortex 目前正在開發快速診斷試劑盒，以檢測來自尿液和唾液的腦震盪和輕度創傷性腦損傷。這種快速診斷試劑盒基於腦損傷後體液中發現的特定生物標誌物。這種快速診斷試劑盒可以幫助提高對腦損傷的檢測，尤其是對有害且難以通過現代手段診斷的輕微腦損傷。正在開發基於聚醣的生物標誌物，用於檢測輕度創傷性腦損傷。

預計在預測期內，對新型創傷產品的批准不斷增加將刺激市場增長。例如，2019 年 12 月，OrthoGrid Systems, Inc. 獲得了美國食品藥品監督管理局（Food and Drug Administration）（ FDA ）的 PhantomMSK Trauma 批准。 OrthoGrid Systems 的 PhantomMSK 是一個通用軟件平台，可與所有製造商的儀器在多個程序中協同工作，以幫助進行透視植入物、儀器和解剖對齊。在骨科手術中，唯一能有效糾正由外部電磁干擾引起的圖像失真現象的術中對齊技術，以及平面圖像映射到彎曲的輸入熒光團，影響圖像完整性並存在潛在的錯位風險。

2020 年 1 月，vasopharm GmbH 完成了關鍵歐洲臨床試驗 NOSTRA III（創傷性腦損傷中的 NO 合□）的患者登記。 NOSTRA III 是一項 III 期臨床試驗，旨在測試 lonopternin (VAS203) 在中度至重度閉合性頭部創傷性腦損傷 (TBI) 患者中的療效和安全性。

預計缺乏熟練的專業人員和高昂的程序成本將阻礙市場增長。

這些程序的成本越來越高、缺乏熟練的專業人員以及缺乏對這些創傷產品的了解是可能在預測期內抑制市場增長的一些關鍵因素。

行業分析

全球創傷產品市場根據波特五力、監管分析、供應鏈分析和定價分析等各種行業因素對市場進行了深入分析。

細分分析

產品類型細分預計將佔全球創傷產品市場的最大市場份額

創傷產品市場根據內部支架、外部支架和其他創傷產品進行細分。在市場細分中，內部夾具佔據了最高的市場份額。內固定裝置包括板、螺釘、釘子和其他內固定裝置。更短的住院時間、更少的疤痕和瘀傷以及更快的患者康復等好處正在推動內固定裝置的採用。 Accumed 的 Acu-Loc 2 手腕板系統提供 48 種板選項，包括遠端和近端坐板、三個板擴展選項和片段特定板。它具有用於骨折管理和骨板定位的創新儀器。該系統用於恢復經歷過骨折、融合或截骨術的人的腕骨的自然解剖結構。 Zimmer Natural Nail System 是下一代髓內釘系統，旨在簡化手術前後的操作。有了這個系統，釘子的設計就盡可能地符合解剖學和對患者友好，並且器械的設計具有流暢的佈局和直觀的功能。

外固定器具有穩定受損骨骼加速癒合的作用，因此市場有望實現正增長。外固定器廣泛用於治療開放性骨折。外固定器是兒童骨折的首選，因為內固定器對骨骼生長無效。外固定器包括單側固定器、雙側固定器、圓形固定器和混合固定器。圓形固定器在不推薦內固定的長骨骨折中顯示出很高的療效。

此外，市場按手術部位分為上肢和下肢。由於越來越多地採用下肢創傷產品，下肢市場份額最高。摩托車事故通常會導致嚴重的腳踝、腳和大腿受傷。下肢包括臀部和骨盆、小腿、足部和腳踝、大腿和膝蓋的損傷。

由於骨科疾病和運動相關損傷的增加，對上肢創傷產品的需求增加，預計上肢市場將增長。上肢包括手、手腕、肩膀、手臂和肘部受傷。越來越多的公司還提供上肢創傷產品。例如，Zimmer Biomet 為上肢的複雜解剖學和生理學提供範圍廣泛的骨折固定產品。該產品由具有先進技術的植入物和儀器組成，可增強固定、簡化程序並提高準確性。

區域分析

北美佔全球創傷產品市場的最大份額。

按地區分為北美、南美、歐洲、亞太地區、中東和非洲。尤其是北美，由於植入物和設備等產品的高采用率，在創傷產品市場上佔據主導地位。隨著事故案件的增加，遭受外傷的人數也在增加。有許多處理緊急情況的創傷中心。由於技術進步和對新產品的日益認可以及優惠的報銷政策，美國擁有最高的市場份額。幾家製藥和生物技術公司正在努力提高人們對創傷的認識。例如，2019 年 12 月，Kaiser Permanent 與健康一代和探索教育聯盟合作，在全美 25,000 所學校解決創傷和壓力問題，促進社會和情感健康。該計劃將為教師提供技能和資源，以支持學生的心理健康並成功管理自己的情感需求。

由於創傷產品研發活動的增加，預計亞太地區的市場將出現強勁增長。開發創傷產品的公司數量正在增加。由於老年人口不斷增長，包括印度和中國在內的國家預計將出現顯著增長，因為老年人受傷的風險更高。隨著人均醫療支出、醫療支出和私人保險支出的增加，預計在預測期內對創傷護理產品的需求也將增加。

競爭格局

創傷醫學市場是一個競爭激烈的市場，擁有多個國際和國內市場。產品多樣化、收入安全和商機使市場更具競爭力。 Medtronic Plc、Cardinal Health Inc、Stryker Corporation、Smith &Nephew、Depuy Synthes（隸屬於 Johnson &Johnson）、Wright Medical Group N.V、B. Braun Melsungen AG 和 Arthrex, Inc. 是具有重要市場份額的主要市場參與者 我在這裡.

主要參與者專注於產品批准、產品開發、市場開發、專利申請和技術進步等戰略，以保持其市場地位。例如，2019 年 9 月，Allied Corp 就大麻素和□類藥物組合物以及治療創傷後應激障礙 (PTSD) 的方法提交了美國臨時專利申請。

公司正在通過合作、合併、戰略合作夥伴關係和收購在全球範圍內擴張，以增加對創傷產品的需求。例如，2019 年 11 月，Stryker Corporation 簽訂了最終協議，以每股 30.75 美元的價格收購 Wright Medical Group 100% 的已發行股份。收購 Wright Medical 將加強 Stryker 在市場上的創傷和四肢業務。

2020 年 1 月，ATAI Life Sciences AG 與 Neuronasal Inc. 建立合作夥伴關係，以開發一種用於輕度創傷性腦損傷 (mTBI) 或腦震蕩的短期治療方法。

2019 年 12 月，Therapeutic Solutions International 獲得專利成人幹細胞的獨家授權，以治療運動和田徑領域的慢性創傷性腦病 (CTE) 和創傷性腦損傷 (TBI) 簽署了一份意向書。

2020 年 1 月，Anika Therapeutics, In 同意收購領先的私營運動醫學公司 Parcus Medical 和領先的私營活動患者關節表面保存解決方案 Arthrosurface。這些收購將有助於擴大公司用於關節保護和修復的替代和再生療法產品組合。

值得關注的重點公司

美敦力PLC

概述 Medtronic, Inc. 是一家在美國運營的醫療器械製造和銷售公司，總部位於美國明尼阿波利斯。它在大約 140 個國家開展業務，擁有 90,000 名員工。

按產品類型劃分的投資組合。

VARILOC：VARILOC 鎖定加壓鋼板系統具有角度穩定鎖定鋼板的優勢，可更好地固定骨質疏鬆症和乾□端骨折。與傳統的板螺釘方法相比，鎖定機構還確保了血液供應。在美敦力-康輝創傷產品下開發。

重大進展。 2022 年 5 月，醫療保健技術領導者 Medtronic plc 宣布收購 Intersect ENT。他們將通過一系列創新產品擴大公司的耳鼻喉產品組合。

全球創傷產品市場報告提供大約 45 多個市場數據表、40 多個數字和 180 頁內容。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 創傷發生率增加
      • 技術進步的增加
    • 限制因素
      • 缺乏熟練的員工
      • 治療費用高
    • 商機
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析

第 6 章按產品類型分析

  • 內固定器
    • 盤子
    • 螺絲
    • 釘子
    • 其他內部固定裝置
  • 外部夾具
    • 單側和雙側固定
    • 圓形固定器
    • 混合夾具
  • 其他創傷產品

第 7 章按手術部位

  • 上肢
    • 手/手腕
    • 肩部
    • 武器
    • 彎頭
  • 下肢
    • 髖關節和骨盆
    • 下肢
    • 腳/腳踝
    • 大腿
    • 膝蓋

第 8 章最終用戶

  • 醫院和創傷中心
  • 門診手術中心

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按產品類型進行基準測試
  • 值得關注的重點公司列表

第 11 章公司簡介

  • 美敦力公司
    • 公司概況
    • 按產品類型劃分的產品組合和內容
    • 主要亮點
    • 財務摘要
  • Cardinal Health Inc.
  • Stryker Corporation
  • Smith & Nephew
  • Depuy Synthes（A part of Johnson & Johnson）
  • Zimmer Biomet Holdings Inc.
  • Integra Lifesciences Holdings Corporation
  • Wright Medical Group N.V
  • B. Braun Melsungen AG
  • Arthrex, Inc.

第12章 全球外傷用品市場-DataM

簡介目錄
Product Code: DMMD2395

Market Overview

Trauma Products Market size was valued US$ 8,149 million in 2021 and is estimated to reach US$ 13,267 million by 2029, growing at a CAGR of 6.5% during the forecast period (2022-2029).

Trauma is referred to as physical injuries, including fractures, burns, sprains, dislocations, and strains that occurred suddenly and required immediate medical attention. The market is dominated by the availability of trauma products, including internal fixators, external fixators, sports medicine devices, cages, angled blades, power tools, arc bars, and other trauma products.

Market Dynamics

The global trauma products market is growing due to several factors such as increasing the number of people undergoing traumatic injuries worldwide, approval of novel traumatic products and novel technological advances.

Rising incidence of traumatic injuries and various new technological advancements are expected to drive market growth.

The rising demand for trauma products drives the market, increasing the number of people undergoing traumatic injuries worldwide. According to the World Health Organization (WHO), approximately 5 million people die every year due to traumatic injuries including traffic collisions, drowning, poisoning, falls or burns, and violence from assault, self-inflicted violence, or acts of war worldwide. Every year approximately, 30% of people aged group 65 years or more fall, and around 40% of the aged group above 75 years fall. Around 40-60% of falls lead to injuries, 10% result in serious injuries, and 5% being fractured.

The market is witnessing technological advancement in diagnostic trauma products for improving the detection of brain injury. For instance, Medicortex is currently developing a rapid diagnostic kit to detect concussion and mild traumatic brain injury from urine or saliva. The rapid diagnostic kit is based on the specific biomarkers discovered from body fluids following brain injury. The rapid diagnostic kit would help improve the detection of brain injury, especially in mild cases that are harmful and difficult to diagnose by using contemporary means. It is being developed by using glycan-based biomarkers for the detection of mild traumatic brain injury.

The increase in the approval of novel trauma products shall stimulate market growth over the forecasted period. For instance, in December 2019, OrthoGrid Systems, Inc. had received clearance from the U.S. Food and Drug Administration (FDA) for the PhantomMSK Trauma. The OrthoGrid Systems' PhantomMSK is a universal software platform that works with all manufacturer devices across multiple procedures to assist with an implant, instrument, and anatomic alignment that use fluoroscopic imaging. It is the only intraoperative alignment technology effective in correcting the phenomenon of image distortion in orthopedic surgery, attributed to external electromagnetic interference and the mapping of the planar image on a curved input phosphor, affecting image integrity and causing potential risks of malalignment.

In January 2020, vasopharm GmbH completed the patient enrollment into the pivotal European NOSTRA III (NO Synthase in Traumatic Brain Injury) clinical trial. NOSTRA III is a Phase III clinical trial for examining the efficacy and safety of Ronopternin (VAS203) for the treatment of moderately to severely injured closed head traumatic brain (TBI) injury patients.

Scarcity of skilled professionals and high cost of procedures are expected to hamper the market growth.

High cost of these procedures that are increasing, scarcity of skilled professionals and unawareness about these trauma products are some key factors that may restraint the growth of market during the forecast period.

Industry Analysis

The global trauma products market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis.

Segment Analysis

Product type segment is expected to hold the largest market share in global trauma products market

The trauma products market is segmented based on internal fixators, external fixators, and other trauma products. The internal fixators segment accounts for the highest market share. The internal fixators segment includes the plates, screws, nails, and other internal fixators. There is higher adoption of the internal fixators due to their advantages in providing shorter hospital stay, less scarring and bruising, and early functionality for patients. Acumed's Acu-Loc 2 Wrist Plating System provides 48 plate options, including distal and proximal sitting plates, three different plate extension options, and fragment-specific plating choices. It features innovative instrumentation for fracture management and plate positioning. It is used to restore the natural anatomy of the wrist bones among people with fractures, fusions, and osteotomies. The Zimmer Natural Nail System is a next-generation intramedullary nailing system designed to make the surgery experience easy from pre-op to close. This system is used for designing the nails as anatomical and patient-conscious as possible, and instruments are designed to be fluid in layout and intuitive in function.

The external fixators are expected to have positive market growth due to their efficiency in speeding up the healing process by stabilizing the damaged bones. The external fixators are widely used for the treatment of open fractures. These external fixators are the preferred choice for fractures in children as internal fixators are not effective in growing bones. The external fixators include the unilateral & bilateral fixators, circular fixators, and hybrid fixators. Circular fixators have demonstrated high efficacy for long bone fractures where internal fixation is not recommended.

Further, the market is also classified based on the surgical site as upper extremities and lower extremities. The lower extremities segment accounts for the highest market share due to higher adoption of the lower extremities trauma product. The number of motorcycle accidents leads to severe injury to the ankle, foot, and thigh. The lower extremities segment includes the injury to the hip & pelvic, lower leg, foot & ankle, thigh, knee.

The upper extremities segment is expected to have positive market growth owing to the rising demand for upper extremities trauma products with the increasing prevalence of orthopedic diseases & sports-related injuries. The upper extremities segment includes the injury to the hand, wrist, shoulder, arm, and elbow. There is an increase in the number of companies providing upper extremities trauma products. For instance, Zimmer Biomet provides a wide range of fracture fixation products for the intricate anatomy and physiology of the upper extremities. It comprises implants and instruments with advanced technologies to enhance fixation, simplify, and improve the accuracy of procedures.

Geographical Analysis

North America region holds the largest market share in the global trauma products market

By region, the trauma products market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the trauma products market due to the high rate of adoption rate products, including implants and devices. There is an increase in the number of people suffering from traumatic injuries with the rising accidental cases. There is a large number of trauma centers handling emergencies. The United States accounts for the highest market share due to the rise in the approval of novel products with technological advancement and the favorable reimbursement policy's availability. Several pharmaceutical and biotechnology companies are involved in creating awareness regarding the trauma. For instance, in December 2019, Kaiser Permanent had entered into a partnership with the Alliance for a Healthier Generation and Discovery Education to address trauma and stress and promote social and emotional wellness at 25,000 schools in the United States. This initiative would provide the teachers with the skills and resources to support students' mental health and better tend to their own emotional needs.

The Asia Pacific region is expected to have positive market growth due to increased research and development activities for trauma products. There is a rising number of companies developing trauma products. Substantial growth is expected to observe in the countries including India and China due to the increasing older population as older people are at a high risk of developing traumatic injuries. The demand for trauma products is expected to increase with the increasing per-capita healthcare, healthcare expenditure, and private insurance expenditure over the forecasted period.

Competitive Landscape

The trauma products market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Medtronic Plc, Cardinal Health Inc., Stryker Corporation, Smith & Nephew, Depuy Synthes (part of Johnson & Johnson), Wright Medical Group N.V, B. Braun Melsungen AG, and Arthrex, Inc. are the leading market players with significant market share.

The key players focus on product approval, product development, market expansion, patent filing, and technological advancement strategies for holding their position in the market. For instance, in September 2019, Allied Corp had filed the United States Provisional Patent Application for cannabinoid and terpenoid pharmaceutical compositions and methods for treating post-traumatic stress disorder (PTSD).

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for trauma products and their expansion across the globe. For instance, in November 2019, Stryker corporation had entered into the definitive agreement to acquire 100% of the issued and outstanding right Medical Group shares for USD 30.75 per share. The acquisition of Wright Medical would strengthen Stryker's trauma and extremities business in the market.

In January 2020, ATAI Life Sciences AG had entered into the collaboration with Neuronasal Inc. to develop the short-term treatment for mild Traumatic Brain Injury (mTBI) or concussion.

In December 2019, Therapeutic Solutions International signed the Letter of Intent to license exclusive rights to a patented adult stem cell to treat chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI) in the field of sports and athletics.

In January 2020, Anika Therapeutics, In, agreed to acquire Parcus Medical, a leading, privately-held sports medicine company, and Arthrosurface, a leading, privately-held provider of joint surf preservation solutions for active patients. These acquisitions would help the company expand its portfolio into replacement and regenerative therapies for joint preservation and restoration.

Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquartered in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Type Portfolio:

VARILOC: VARILOC locking compression plate system provides the advantages of locking plate that gives angle stability to get better fixation in osteoporosis and metaphyseal fractures. Its locking mechanism offers better blood supply preservation as compared to conventional plate and screw system. Developed under Medtronic-Kanghui trauma products.

Key Developments: In May 2022, Medtronic plc, leader in healthcare technology announced its acquisition of Intersect ENT. They will expand company's ear, nose and throat portfolio with various innovative products.

The global trauma products market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Rising Incidence of traumatic injuries
      • 4.1.1.2. Increasing technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled staff
      • 4.1.2.2. High cost associated with procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 6.1.2. Market Attractiveness Index, By Product Type Segment
  • 6.2. Internal Fixators
      • 6.2.1.1. Introduction
      • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
      • 6.2.1.3. Plates
      • 6.2.1.4. Screws
      • 6.2.1.5. Nails
      • 6.2.1.6. Other Internal Fixators
  • 6.3. External Fixators
    • 6.3.1. Unilateral & Bilateral Fixators
    • 6.3.2. Circular Fixators
    • 6.3.3. Hybrid Fixators
  • 6.4. Other Trauma Products

7. By Surgical Site

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site Segment
    • 7.1.2. Market Attractiveness Index, By Surgical Site Segment
  • 7.2. Upper Extremities
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Hand & Wrist
    • 7.2.4. Shoulder
    • 7.2.5. Arms
    • 7.2.6. Elbow
  • 7.3. Lower Extremities
    • 7.3.1. Hip & Pelvic
    • 7.3.2. Lower Leg
    • 7.3.3. Foot & Ankle
    • 7.3.4. Thigh
    • 7.3.5. Knee

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 8.1.2. Market Attractiveness Index, By End User Segment
  • 8.2. Hospitals & Trauma Centers
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Ambulatory Surgery Centers

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Types Benchmarking
  • 10.4. List of Key Companies to Watch

11. Company Profiles

  • 11.1. Medtronic Plc
    • 11.1.1. Company Overview
    • 11.1.2. Product Type Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Cardinal Health Inc.
  • 11.3. Stryker Corporation
  • 11.4. Smith & Nephew
  • 11.5. Depuy Synthes (A part of Johnson & Johnson)
  • 11.6. Zimmer Biomet Holdings Inc.
  • 11.7. Integra Lifesciences Holdings Corporation
  • 11.8. Wright Medical Group N.V
  • 11.9. B. Braun Melsungen AG
  • 11.10. Arthrex, Inc.

LIST NOT EXHAUSTIVE

12. Global Trauma Products Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and End User
  • 12.3. Contact Us